Browse > Article
http://dx.doi.org/10.5352/JLS.2021.31.6.603

Analysis of Physical Status on COVID-19: Based on Impacts of Physical Activity  

Kim, Kwi-Baek (Department of Marine Leisure and Tourism, Youngsan University)
Kwak, Yi Sub (DEU-Exe-Physio Lab, Department of Physical education, Dong-Eui University, College of arts, Design and Sports Science)
Publication Information
Journal of Life Science / v.31, no.6, 2021 , pp. 603-608 More about this Journal
Abstract
The purpose of this perspective research is to discuss the potential role of exercise-interventions in COVID-19, terms of prevention and prognosis in the periods of the COVID-19 vaccine. SARCO-CoV-2. COVID-19 was detected as a new virus causing severe cardiovascular and respiratory complications. It emerged as a global public health emergency and national pandemic. It caused more than 1 million deaths in the first 6 months of the pandemic and resulted in huge social and economic fluctuations internationally. Unprecedented stressful situations, such as COVID-19 blue and COVID-19 red impact on many health problems. In healthy individuals, COVID-19 infection may induced no symptoms (i.e., asymptomatic), whereas others may experience flu-like symptoms, such as ARDS, pneumonia, and death. Poor health status, such as obesity and cardiovascular and respiratory complications, are high risk factors for COVID-19 prevention, occurrence, and prognosis. Several COVID-19 vaccines are currently in human trials. However, the efficacy and safety of COVID-19 vaccines, including potential side effects, such as anaphylaxis (a life-threatening allergic reaction) and rare blood clots, still need to be investigated. On the basis of direct and indirect evidence, it seems that regular and moderate physical exercise can be recommended as a nonpharmacological, efficient, and safe way to cope with COVID-19. Physical inactivity and metabolic abnormalities are directly associated with reduced immune responses, including reduced innate, CMI, and AMI responses. Due to prolonged viral shedding, quarantine in inactive, obese and disease people should likely be longer than physical active people. Multicomponent and systemic exercise should be considered for the obese, disease, and elderly people. More mechanism research is needed in this area.
Keywords
COVID-19 vaccine; exercise-intervention; national pandemic; non-pharmacological;
Citations & Related Records
연도 인용수 순위
  • Reference
1 Chusunilbo. 2021. COVID-19 and telemedicine, opinion section, May, 17
2 Chusunilbo. 2021. COVID-19 and summer festival, society section, May, 22.
3 Chusunilbo. 2021. COVID-19 vaccine, take a vaccine section, May, 28.
4 Chusunilbo. 2021. COVID-19 jansen vaccine, today section, June, 1
5 Jung, Y. S., Park, J. H., Park, D., Shon, C. L. and Lee, J. M. 2018. Physical inactivity and unhealthy metabolic status are associated with decreased national killer cell activity. Yonsei Med. J. 59, 554-562.   DOI
6 Kim, C. S. 2021. Exercise science and COVID-19. Exerc. Sci. 30, 1-2.   DOI
7 Kukje newspaper. 2021. The acceleration of COVID-19 vaccine, international section. May, 6.
8 Luzi, L. and Radaelli, M. G. 2020. Influenza and obesity: its odd relationship and the lessons for covid-19 pandemic. Acta. Diabetol. 57, 759-764.   DOI
9 Richards, A. 2020. Ethical guidelines for deliberately infecting volunteers with covid-19. J. Med. Ethics 46, 502-504.   DOI
10 Severin, R., Arena, R., Lavie, C. J., Bond, S. and Phillips, S. A. 2020. Respiratory muscle performance screening for infectious disease management following covid-19: a highly pressurized situation. Am. J. Med. 133, 1025-1032.   DOI
11 Soiza, R. L., Scicluna, C. and Thomson, E. C. 2021. Efficacy and safety of COVID-19 vaccines in older people. Age Ageing 50, 279-283.   DOI
12 Lazarus, J. V., Ratzan, S. C., Palayew, A., Gostin, L. O., Larson, H. J., Rabin, K., Kimball, S. and EL-Mohandes, A. 2021. A global survey of potental acceptance of a covid-19 vaccine. Nat. Med. 27, 225-228.   DOI
13 Chusunilbo. 2021. COVID-19 vaccine swap, covid-19 section, Apr, 21.
14 Kukje newspaper. 2021. COVID-19 and intestine health, health section. May, 11.
15 Laddu, D. R., Lavie, C. J. and Phillips, S. A. 2020. Physical activity for immunity protection: Inoculating populations with healthy living medicine in preparation for the next pandemic. Prog. Cardiovasc. Dis. 64, 102-104.
16 Chusunilbo. 2021. AZ COVID-19 vaccine, headline section, Mar, 1.
17 Mann, R. H., Clift, B. C., Boyokoff, J. and Bekker, S. 2020. Athletes as community; covid-19, sporting mega-events and athlete health protection. Br. J. Sport. Med. 54, 1071-1072.   DOI
18 Sharma, O., Sultan, A. A., Ding, H. and Triggle, C. R. 2020. A review of the progress and challenges of developing a vaccine for COVID-19. Front. Immunol. 11, 585354.   DOI
19 CDC COVID-19 Response Team, Food and Drug Administration. 2021. Allergic reactions including anaphylaxis after receipt of the first dose of Pfizer-bioNTech COVID-19 Vaccine-united states, December 14-23. MMWR. Morb. Mortal. Wkly. Rep. 70, 46-51.   DOI
20 Chusunilbo. 2021. COVID-19 mutant virus emergency, covid-19 section. Apr, 9.
21 Chusunilbo. 2021. COVID-19 blue, focus section, Apr, 24.
22 Chusunilbo. 2021. COVID-19 vaccine and side effects, health section. May, 6.
23 Chusunilbo. 2021. COVID-19 and Tokyo olympic, today section, May, 26.
24 Kukje newspaper. 2021. AZ COVID-19 vaccine and side effects, health section. Apr, 12.
25 Chusunilbo. 2021. COVID-19 and home training, health section, Apr, 22.
26 Chusunilbo. 2021. COVID-19 vaccine and Lotto, world section. May, 14.
27 Ji, J. G., Kim, K. B. and Kwak, Y. S. 2020. The practical impacts of exercise-intervention on COVID-19 pandemic. Exerc. Sci. 29, 339-346.   DOI
28 Chusunilbo. 2021. COVID-19 vaccine and ventilation system, health section. Apr, 8.
29 Chusunilbo. 2021. COVID-19 vaccine and side effects, covid-19 section. May, 10.
30 Chusunilbo. 2021. COVID-19 and population reduction, society section. May, 14.
31 Zheng, Y. Y., Ma, Y. T., Zhang, J. Y. and Xie, X. 2020. Covid-19 and the cardiovascular system. Nat. Rev. Cardiol. 17, 259-260.   DOI
32 Chusunilbo. 2021. COVID-19 vaccine intellectual property right exemption, international section, May, 8.